Early mobilization in ICU may not reduce mortality or hospital stay: NEJM Dr. Kamal Kant Kohli2 Nov 2022 8:00 PM ISTMelbourne: A trial presented at the LIVES 2022 meeting of the European Society of Intensive Care Medicine in Paris and published in the New England...
Spontaneous-breathing trials with pressure-support ventilation no better than trials using T-piece: NEJM Medha Baranwal27 Oct 2022 8:00 PM ISTFrance: Among patients with a high risk of extubation failure, the use of pressure-support ventilation (PSV) fails to increase ventilator-free days at...
Ruxolitinib cream associated with higher repigmentation of vitiligo lesions, study says Medha Baranwal26 Oct 2022 8:00 PM ISTUSA: Results from two phase 3 trials published in the New England Journal of Medicine showed that the application of ruxolitinib cream led to a...
Medical Bulletin 21/October/2022 Isra Zaman21 Oct 2022 4:45 PM ISTHere are the top medical news for the day:Inflammatory bowel disease risk increased by environmental chemicalsInflammatory bowel disease (IBD), a...
Depression risk increased with hours worked in stressful jobs: Study Isra Zaman21 Oct 2022 9:15 AM ISTThe more hours someone works each week in a stressful job, the more their risk of depression rises, a study in new doctors finds. Working 90 or more...
Use of open-source automated insulin delivery tied to better target blood sugar range: NEJM Dr Kartikeya Kohli14 Oct 2022 8:00 PM ISTNew Zealand: The use of open-source automated insulin delivery (AID) systems versus a sensor-augmented insulin pump in adults and children having type...
Thrombectomy after stroke due to basilar-artery occlusion improves functional status: BAOCHE trial Medha Baranwal13 Oct 2022 11:15 AM ISTUSA: Endovascular thrombectomy 6 to 24 hours after stroke onset due to basilar-artery occlusion led to a higher percentage with good functional status...
Intravenous immunoglobulin effective against dermatomyositis: NEJM Medha Baranwal6 Oct 2022 7:30 PM ISTDelhi: Intravenous immune globulin (IVIG) treatment in patients with dermatomyositis confers more significant improvement in disease activity compared...
FDA approves Relyvrio as new treatment option for ALS Dr. Kamal Kant Kohli3 Oct 2022 11:30 AM ISTThe Food and Drug Administration (FDA) has granted approval to a new treatment option in form of Relyvrio (sodium phenylbutyrate and taurursodiol) for...
Liraglutide and insulin glargine score over other diabetes drugs for diabetics already maintained on metformin Medha Baranwal24 Sept 2022 10:00 AM ISTLiraglutide and insulin glargine performed the best of other FDA-approved glucose-lowering medications to maintain blood glucose levels in the...
Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sept 2022 8:30 PM ISTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older Ruchika Sharma14 Sept 2022 12:20 PM ISTGaithersburg: Novavax, Inc., a biotechnology company and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by...
